These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38217745)
1. Numerical study of ultra-large von Willebrand factor multimers in coagulopathy. Rahmati N; Keshavarz Motamed P; Maftoon N Biomech Model Mechanobiol; 2024 Jun; 23(3):737-756. PubMed ID: 38217745 [TBL] [Abstract][Full Text] [Related]
2. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall. Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805 [TBL] [Abstract][Full Text] [Related]
3. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388 [TBL] [Abstract][Full Text] [Related]
4. Platelets and von Willebrand factor. Schmugge M; Rand ML; Freedman J Transfus Apher Sci; 2003 Jun; 28(3):269-77. PubMed ID: 12725954 [TBL] [Abstract][Full Text] [Related]
5. Unwinding the von Willebrand factor strings puzzle. De Ceunynck K; De Meyer SF; Vanhoorelbeke K Blood; 2013 Jan; 121(2):270-7. PubMed ID: 23093621 [TBL] [Abstract][Full Text] [Related]
7. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood. Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606 [TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion. Chung DW; Chen J; Ling M; Fu X; Blevins T; Parsons S; Le J; Harris J; Martin TR; Konkle BA; Zheng Y; López JA Blood; 2016 Feb; 127(5):637-45. PubMed ID: 26552698 [TBL] [Abstract][Full Text] [Related]
9. Disulfide bond reduction of von Willebrand factor by ADAMTS-13. Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172 [TBL] [Abstract][Full Text] [Related]
10. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation. Michels A; Swystun LL; Mewburn J; Albánez S; Lillicrap D J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829426 [TBL] [Abstract][Full Text] [Related]
11. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha. Martin C; Morales LD; Cruz MA J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010 [TBL] [Abstract][Full Text] [Related]
12. Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin. Chauhan AK; Goerge T; Schneider SW; Wagner DD J Thromb Haemost; 2007 Mar; 5(3):583-9. PubMed ID: 17166247 [TBL] [Abstract][Full Text] [Related]
13. The various states of von Willebrand factor and their function in physiology and pathophysiology. Huck V; Schneider MF; Gorzelanny C; Schneider SW Thromb Haemost; 2014 Apr; 111(4):598-609. PubMed ID: 24573248 [TBL] [Abstract][Full Text] [Related]
14. Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease. Gritsch H; Schrenk G; Weinhappl N; Mellgård B; Ewenstein B; Turecek PL J Blood Med; 2022; 13():649-662. PubMed ID: 36405429 [TBL] [Abstract][Full Text] [Related]
15. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Stockschlaeder M; Schneppenheim R; Budde U Blood Coagul Fibrinolysis; 2014 Apr; 25(3):206-16. PubMed ID: 24448155 [TBL] [Abstract][Full Text] [Related]
16. Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network. Barg A; Ossig R; Goerge T; Schneider MF; Schillers H; Oberleithner H; Schneider SW Thromb Haemost; 2007 Apr; 97(4):514-26. PubMed ID: 17393012 [TBL] [Abstract][Full Text] [Related]
17. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Moake JL; Turner NA; Stathopoulos NA; Nolasco L; Hellums JD Blood; 1988 May; 71(5):1366-74. PubMed ID: 3258770 [TBL] [Abstract][Full Text] [Related]
18. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. Dong JF J Thromb Haemost; 2005 Aug; 3(8):1710-6. PubMed ID: 16102037 [TBL] [Abstract][Full Text] [Related]
19. Coarse-grained simulations of von Willebrand factor adsorption to collagen with consequent platelet recruitment. Tsyu NG; Belyaev AV Int J Numer Method Biomed Eng; 2023 Nov; 39(11):e3747. PubMed ID: 37366014 [TBL] [Abstract][Full Text] [Related]
20. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets. Cooney KA; Lyons SE; Ginsburg D Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]